Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Daily Regenerator Dentalclean is a remineralizing dentifrice developed by the Brazilian oral care company Dentalclean, incorporating the proprietary REFIX technology. This technology is designed to promote the regeneration of tooth enamel and provide a protective mineral layer to address initial dental caries and enamel erosion. The formulation works by enhancing the bioavailability and retention of fluoride and other essential minerals in the dental biofilm and saliva, facilitating the formation of fluorapatite and restoring the mineral structure of the tooth surface. It is available in different variants, such as Neutral (RDCN) and Acid (RDCA), which are studied for their efficiency in fluoride bioavailability and long-term oral exposure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Daily Regenerator Dentalclean.